{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:56:11Z","timestamp":1774544171055,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","award":["HB2023116"],"award-info":[{"award-number":["HB2023116"]}],"id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102150"],"award-info":[{"award-number":["82102150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103135"],"award-info":[{"award-number":["82103135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20210968"],"award-info":[{"award-number":["BK20210968"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2020708"],"award-info":[{"award-number":["BE2020708"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03523-1","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T13:01:43Z","timestamp":1725714103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Shuya","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenggang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"issue":"1","key":"3523_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3523_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"3523_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","volume":"261","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947\u201355.","journal-title":"Ann Surg"},{"key":"3523_CR4","doi-asserted-by":"crossref","unstructured":"Zhou Z, Liu J, Xu X. A commentary on \u2018Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study\u2019 (Int J Surg. 2022;105:106843). Int J Surg. 2023;109(11):3656\u20133658.","DOI":"10.1097\/JS9.0000000000000119"},{"issue":"1","key":"3523_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","volume":"9","author":"H He","year":"2023","unstructured":"He H, Chen S, Fan Z, Dong Y, Wang Y, Li S, et al. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discov. 2023;9(1):60.","journal-title":"Cell Discov"},{"issue":"1","key":"3523_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1478-3231.2010.02348.x","volume":"31","author":"Y Inagaki","year":"2011","unstructured":"Inagaki Y, Tang W, Makuuchi M, Hasegawa K, Sugawara Y, Kokudo N. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-\u03b3-carboxyprothrombin. Liver Int. 2011;31(1):22\u201335.","journal-title":"Liver Int"},{"key":"3523_CR7","doi-asserted-by":"publisher","first-page":"726213","DOI":"10.3389\/fonc.2021.726213","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Li G, Lu Z, Liu Y, Kong J, Liu J. Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma. Front Oncol. 2021;11:726213.","journal-title":"Front Oncol"},{"issue":"1","key":"3523_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/ijms25010597","volume":"25","author":"M Shah","year":"2024","unstructured":"Shah M, Sarkar D. HCC-Related lncRNAs: roles and mechanisms. Int J Mol Sci. 2024;25(1):597.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3523_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43556-024-00184-0","volume":"5","author":"Y Xue","year":"2024","unstructured":"Xue Y, Ruan Y, Wang Y, Xiao P, Xu J. Signaling pathways in liver cancer: pathogenesis and targeted therapy. Mol Biomed. 2024;5(1):20.","journal-title":"Mol Biomed"},{"issue":"16","key":"3523_CR10","doi-asserted-by":"publisher","first-page":"9430","DOI":"10.3390\/ijms23169430","volume":"23","author":"T Androutsakos","year":"2022","unstructured":"Androutsakos T, Bakasis AD, Pouliakis A, Gazouli M, Vallilas C, Hatzis G. Single nucleotide polymorphisms of toll-like receptor 4 in Hepatocellular Carcinoma-A single-center study. Int J Mol Sci. 2022;23(16):9430.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3523_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/annonc\/mdz103","volume":"30","author":"LX Xu","year":"2019","unstructured":"Xu LX, He MH, Dai ZH, Yu J, Wang JG, Li XC, et al. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;30(6):990\u20137.","journal-title":"Ann Oncol"},{"issue":"6","key":"3523_CR12","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365.","journal-title":"Hepatology"},{"issue":"4","key":"3523_CR13","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00330-022-09282-5","volume":"33","author":"P Huang","year":"2023","unstructured":"Huang P, Zhou C, Wu F, Xiao Y, Qian X, Wang Y, et al. An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI. Eur Radiol. 2023;33(4):2735\u201345.","journal-title":"Eur Radiol"},{"issue":"3","key":"3523_CR14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","volume":"7","author":"HA Edmondson","year":"1954","unstructured":"Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462\u2013503.","journal-title":"Cancer"},{"issue":"3","key":"3523_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3350\/cmh.2023.0034","volume":"29","author":"YJ Hwang","year":"2023","unstructured":"Hwang YJ, Bae JS, Lee Y, Hur BY, Lee DH, Kim H. Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging. Clin Mol Hepatol. 2023;29(3):733\u201346.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"3523_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ejso.2011.03.137","volume":"37","author":"L Zhou","year":"2011","unstructured":"Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur J Surg Oncol. 2011;37(6):521\u20135.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"3523_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","volume":"70","author":"X Xu","year":"2019","unstructured":"Xu X, Zhang HL, Liu QP, Sun SW, Zhang J, Zhu FP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133\u201344.","journal-title":"J Hepatol"},{"issue":"4","key":"3523_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","volume":"151","author":"Z Lei","year":"2016","unstructured":"Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma within the Milan Criteria. JAMA Surg. 2016;151(4):356\u201363.","journal-title":"JAMA Surg"},{"issue":"1","key":"3523_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/hbsn-19-870","volume":"11","author":"Y Mao","year":"2022","unstructured":"Mao Y, Wang J, Zhu Y, Chen J, Mao L, Kong W, et al. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2022;11(1):13\u201324.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"7","key":"3523_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s11605-023-05670-4","volume":"27","author":"GC Park","year":"2023","unstructured":"Park GC, Hwang S, You YK, Choi Y, Kim JM, Joo DJ, et al. Quantitative prediction of Posttransplant Hepatocellular Carcinoma Prognosis using ADV score: validation with Korea-Nationwide Transplantation Registry Database. J Gastrointest Surg. 2023;27(7):1353\u201366.","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"3523_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/jhbp.1319","volume":"30","author":"WH Kang","year":"2023","unstructured":"Kang WH, Hwang S, Kaibori M, Kim JM, Kim KS, Kobayashi T, et al. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients. J Hepatobiliary Pancreat Sci. 2023;30(8):993\u20131005.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"10","key":"3523_CR22","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s11605-021-04939-w","volume":"25","author":"S Hwang","year":"2021","unstructured":"Hwang S, Song GW, Ahn CS, Kim KH, Moon DB, Ha TY, et al. Quantitative prognostic prediction using ADV score for Hepatocellular Carcinoma following living Donor Liver Transplantation. J Gastrointest Surg. 2021;25(10):2503\u201315.","journal-title":"J Gastrointest Surg"},{"key":"3523_CR23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2147\/JHC.S339707","volume":"8","author":"S Mao","year":"2021","unstructured":"Mao S, Yu X, Shan Y, Fan R, Wu S, Lu C. Albumin-Bilirubin (ALBI) and Monocyte to lymphocyte ratio (MLR)-Based Nomogram Model to Predict Tumor recurrence of AFP-Negative Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:1355\u201365.","journal-title":"J Hepatocell Carcinoma"},{"issue":"8","key":"3523_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","volume":"65","author":"M Lemoine","year":"2016","unstructured":"Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65(8):1369\u201376.","journal-title":"Gut"},{"issue":"5","key":"3523_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.14218\/JCTH.2021.00345","volume":"10","author":"S Lu","year":"2022","unstructured":"Lu S, Xu L, Liang B, Wang H, Wang T, Xiang T, et al. Liver function derangement in patients with severe fever and Thrombocytopenia Syndrome. J Clin Transl Hepatol. 2022;10(5):825\u201334.","journal-title":"J Clin Transl Hepatol"},{"key":"3523_CR26","first-page":"204993612110501","volume":"8","author":"RO Oladele","year":"2021","unstructured":"Oladele RO, Otu AA, Balogun OJ, Babalola OM, Nwosu AO, Iyabo Osaigbovo I, et al. Standardization of aspergillus IgG diagnostic cutoff in nigerians. Ther Adv Infect Dis. 2021;8:20499361211050158.","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"3523_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0333102418771375","volume":"39","author":"MA Chalmer","year":"2019","unstructured":"Chalmer MA, Hansen TF, Olesen J. Nosographic analysis of osmophobia and field testing of diagnostic criteria including osmophobia. Cephalalgia. 2019;39(1):38\u201343.","journal-title":"Cephalalgia"},{"issue":"3","key":"3523_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/SLA.0000000000002486","volume":"269","author":"DH Jung","year":"2019","unstructured":"Jung DH, Hwang S, Lee YJ, Kim KH, Song GW, Ahn CS, et al. Small Hepatocellular Carcinoma with low tumor marker expression benefits more from Anatomical Resection Than Tumors with Aggressive Biology. Ann Surg. 2019;269(3):511\u20139.","journal-title":"Ann Surg"},{"issue":"11","key":"3523_CR29","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s11605-016-3187-y","volume":"20","author":"S Hwang","year":"2016","unstructured":"Hwang S, Song GW, Lee YJ, Kim KH, Ahn CS, Moon DB, et al. Multiplication of Tumor volume by two tumor markers is a Post-resection Prognostic Predictor for Solitary Hepatocellular Carcinoma. J Gastrointest Surg. 2016;20(11):1807\u201320.","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"3523_CR30","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00268-018-4468-2","volume":"42","author":"S Hwang","year":"2018","unstructured":"Hwang S, Joh JW, Wang HJ, Kim DG, Kim KS, Suh KS, et al. Prognostic prediction models for resection of large Hepatocellular Carcinoma: a Korean Multicenter Study. World J Surg. 2018;42(8):2579\u201391.","journal-title":"World J Surg"},{"issue":"6","key":"3523_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4174\/astr.2018.95.6.303","volume":"95","author":"SM Ha","year":"2018","unstructured":"Ha SM, Hwang S, Park JY, Lee YJ, Kim KH, Song GW, et al. Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas. Ann Surg Treat Res. 2018;95(6):303\u201311.","journal-title":"Ann Surg Treat Res"},{"issue":"5","key":"3523_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4174\/astr.2020.98.5.235","volume":"98","author":"GC Park","year":"2020","unstructured":"Park GC, Hwang S, Park YH, Choi JU, Korean Liver Cancer Study Group. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database. Ann Surg Treat Res. 2020;98(5):235\u201346.","journal-title":"Ann Surg Treat Res"},{"issue":"7","key":"3523_CR33","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s11605-020-04800-6","volume":"25","author":"S Hwang","year":"2021","unstructured":"Hwang S, Moon DB, Kim KH, Ahn CS, Song GW, Jung DH, et al. Prognostic accuracy of the ADV score following resection of Hepatocellular Carcinoma with Portal Vein Tumor thrombosis. J Gastrointest Surg. 2021;25(7):1745\u201359.","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"3523_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/jhbp.863","volume":"28","author":"S Hwang","year":"2021","unstructured":"Hwang S, Song GW, Ahn CS, Kim KH, Moon DB, Ha TY, et al. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: quantitative prediction using ADV score. J Hepatobiliary Pancreat Sci. 2021;28(11):1000\u201313.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"3523_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.17998\/jlc.21.1.45","volume":"21","author":"S Hwang","year":"2021","unstructured":"Hwang S, Kim KH, Moon DB, Ahn CS, Ha TY, Song GW, et al. Prediction of post-resection prognosis using the ADV score for huge Hepatocellular Carcinomas\u2009\u2265\u200913\u00a0cm. J Liver Cancer. 2021;21(1):45\u201357.","journal-title":"J Liver Cancer"},{"issue":"1","key":"3523_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4174\/astr.2022.102.1.46","volume":"102","author":"S Hwang","year":"2022","unstructured":"Hwang S, Lee KJ, Moon DB, Song GW, Jung DH, Kim YK, et al. Prognostic impact of serum soluble PD-1 and ADV score for living donor liver transplantation in patients with previously untreated hepatocellular carcinoma. Ann Surg Treat Res. 2022;102(1):46\u201354.","journal-title":"Ann Surg Treat Res"},{"issue":"1","key":"3523_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the study of the liver. EASL Clinical Practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"2","key":"3523_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3350\/cmh.2022.0212","volume":"29","author":"DY Kim","year":"2023","unstructured":"Kim DY, Toan BN, Tan CK, Hasan I, Setiawan L, Yu ML, et al. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clin Mol Hepatol. 2023;29(2):277\u201392.","journal-title":"Clin Mol Hepatol"},{"key":"3523_CR39","doi-asserted-by":"publisher","first-page":"106843","DOI":"10.1016\/j.ijsu.2022.106843","volume":"105","author":"MD Wang","year":"2022","unstructured":"Wang MD, Sun LY, Qian GJ, Li C, Gu LH, Yao LQ, et al. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study. Int J Surg. 2022;105:106843.","journal-title":"Int J Surg"},{"issue":"11","key":"3523_CR40","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1007\/s00330-019-06180-1","volume":"29","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Kuang S, Shan Q, Rong D, Zhang Z, Yang H, et al. Can IVIM help predict HCC recurrence after hepatectomy? Eur Radiol. 2019;29(11):5791\u2013803.","journal-title":"Eur Radiol"},{"issue":"6","key":"3523_CR41","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s11605-023-05624-w","volume":"27","author":"Y Imaoka","year":"2023","unstructured":"Imaoka Y, Ohira M, Kobayashi T, Honmyo N, Hamaoka M, Onoe T, et al. Impact of Geriatric Nutritional Risk Index after initial hepatectomy for Hepatocellular Carcinoma: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO). J Gastrointest Surg. 2023;27(6):1152\u20138.","journal-title":"J Gastrointest Surg"},{"key":"3523_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13027-019-0219-8","volume":"14","author":"C Qu","year":"2019","unstructured":"Qu C, Huang X, Liu K, Li K, Tan B, Qu L, et al. Effect of hepatitis B virus DNA replication level and anti-HBV therapy on microvascular invasion of hepatocellular carcinoma. Infect Agent Cancer. 2019;14:2.","journal-title":"Infect Agent Cancer"},{"key":"3523_CR43","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/JHC.S417878","volume":"10","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Cao S, Chen C, Chen J, Xu X, Liu Y, et al. A Novel Nomogram for the preoperative prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma patients. J Hepatocell Carcinoma. 2023;10:1399\u2013409.","journal-title":"J Hepatocell Carcinoma"},{"issue":"13","key":"3523_CR44","doi-asserted-by":"publisher","first-page":"8174","DOI":"10.1245\/s10434-021-09901-3","volume":"28","author":"S Bai","year":"2021","unstructured":"Bai S, Yang P, Xie Z, Li J, Lei Z, Xia Y, et al. Preoperative estimated risk of Microvascular Invasion is Associated with Prognostic differences following liver resection Versus Radiofrequency ablation for early Hepatitis B Virus-Related Hepatocellular Carcinoma. Ann Surg Oncol. 2021;28(13):8174\u201385.","journal-title":"Ann Surg Oncol"},{"key":"3523_CR45","doi-asserted-by":"publisher","first-page":"goad035","DOI":"10.1093\/gastro\/goad035","volume":"11","author":"P Yang","year":"2023","unstructured":"Yang P, Teng F, Bai S, Xia Y, Xie Z, Cheng Z, et al. Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks. Gastroenterol Rep (Oxf). 2023;11:goad035.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"3523_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s12072-011-9318-3","volume":"6","author":"SC Chan","year":"2011","unstructured":"Chan SC, Fan ST, Chok KS, Cheung TT, Chan AC, Fung JY, et al. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatol Int. 2011;6(3):646\u201356.","journal-title":"Hepatol Int"},{"issue":"4","key":"3523_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/JS9.0000000000000204","volume":"109","author":"XP Zhang","year":"2023","unstructured":"Zhang XP, Xu S, Lin ZY, Gao QL, Wang K, Chen ZL, et al. Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study. Int J Surg. 2023;109(4):679\u201388.","journal-title":"Int J Surg"},{"issue":"4","key":"3523_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.21037\/hbsn-21-223","volume":"11","author":"L Wang","year":"2022","unstructured":"Wang L, Liu Y, Rong W, Wu F, Yu W, Liu K, et al. The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<\u20091\u00a0cm) hepatectomy: a prospective, phase 2 study. Hepatobiliary Surg Nutr. 2022;11(4):515\u201329.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"3523_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/JHC.S356573","volume":"9","author":"T Xu","year":"2022","unstructured":"Xu T, Ren L, Liao M, Zhao B, Wei R, Zhou Z, et al. Preoperative Radiomics analysis of contrast-enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2022;9:189\u2013201.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"3523_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12916-023-03137-6","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Meng B, Wang X, Wu A, Li X, Qian X, et al. Noninvasive urinary protein signatures combined clinical information associated with microvascular invasion risk in HCC patients. BMC Med. 2023;21(1):481.","journal-title":"BMC Med"},{"key":"3523_CR51","doi-asserted-by":"publisher","first-page":"1169102","DOI":"10.3389\/fonc.2023.1169102","volume":"13","author":"Y Liang","year":"2023","unstructured":"Liang Y, Wang Z, Peng Y, Dai Z, Lai C, Qiu Y, et al. Development of ensemble learning models for prognosis of hepatocellular carcinoma patients underwent postoperative adjuvant transarterial chemoembolization. Front Oncol. 2023;13:1169102.","journal-title":"Front Oncol"},{"issue":"39","key":"3523_CR52","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.3748\/wjg.v24.i39.4436","volume":"24","author":"JM O\u2019Rourke","year":"2018","unstructured":"O\u2019Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: implications for the management of hepatocellular cancer. World J Gastroenterol. 2018;24(39):4436\u201347.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3523_CR53","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.dld.2018.09.016","volume":"51","author":"A Casadei Gardini","year":"2019","unstructured":"Casadei Gardini A, Foschi FG, Conti F, Petracci E, Vukotic R, Marisi G, et al. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Dig Liver Dis. 2019;51(5):681\u20138.","journal-title":"Dig Liver Dis"},{"key":"3523_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JHC.S286213","volume":"8","author":"S Li","year":"2021","unstructured":"Li S, Xu W, Liao M, Zhou Y, Weng J, Ren L, et al. The significance of Gamma-Glutamyl transpeptidase to lymphocyte count ratio in the early postoperative recurrence monitoring and prognosis prediction of AFP-Negative Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:23\u201333.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"3523_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12885-020-6628-7","volume":"20","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhou Y, Li Y, Qin W, Zi Y, Liu Y, et al. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion. BMC Cancer. 2020;20(1):132.","journal-title":"BMC Cancer"},{"issue":"10","key":"3523_CR56","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1200\/JCO.22.01142","volume":"41","author":"SH Li","year":"2023","unstructured":"Li SH, Mei J, Cheng Y, Li Q, Wang QX, Fang CK, et al. Postoperative adjuvant hepatic arterial infusion Chemotherapy with FOLFOX in Hepatocellular Carcinoma with Microvascular Invasion: a Multicenter, Phase III, Randomized Study. J Clin Oncol. 2023;41(10):1898\u2013908.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3523_CR57","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","volume":"2","author":"WJ Ho","year":"2021","unstructured":"Ho WJ, Zhu Q, Durham J, Popovic A, Xavier S, Leatherman J, et al. Neoadjuvant Cabozantinib and Nivolumab converts locally Advanced HCC into Resectable Disease with enhanced Antitumor Immunity. Nat Cancer. 2021;2(9):891\u2013903.","journal-title":"Nat Cancer"},{"issue":"3","key":"3523_CR58","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S2468-1253(21)00427-1","volume":"7","author":"AO Kaseb","year":"2022","unstructured":"Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, et al. Perioperative Nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022;7(3):208\u201318.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"13","key":"3523_CR59","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","volume":"16","author":"J Bruix","year":"2015","unstructured":"Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, Kudo M, et al. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2015;16(13):1344\u201354.","journal-title":"Lancet Oncol"},{"issue":"6","key":"3523_CR60","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s12072-020-10111-4","volume":"14","author":"X Sheng","year":"2020","unstructured":"Sheng X, Ji Y, Ren GP, Lu CL, Yun JP, Chen LH, et al. A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC. Hepatol Int. 2020;14(6):1034\u201347.","journal-title":"Hepatol Int"},{"key":"3523_CR61","doi-asserted-by":"publisher","first-page":"173382","DOI":"10.1016\/j.ejphar.2020.173382","volume":"883","author":"Z Wang","year":"2020","unstructured":"Wang Z, Duan Y, Zhang J, Lv Y, Wu S, Cheng M, et al. Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis. Eur J Pharmacol. 2020;883:173382.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"3523_CR62","doi-asserted-by":"publisher","first-page":"e182721","DOI":"10.1001\/jamasurg.2018.2721","volume":"153","author":"Z Li","year":"2018","unstructured":"Li Z, Lei Z, Xia Y, Li J, Wang K, Zhang H, Wan X, et al. Association of Preoperative Antiviral Treatment with incidences of Microvascular Invasion and Early Tumor recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma. JAMA Surg. 2018;153(10):e182721.","journal-title":"JAMA Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03523-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03523-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03523-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:53:17Z","timestamp":1732744397000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03523-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03523-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review boards of The First Affiliated Hospital of Nanjing Medical University and The Affiliated Drum Tower Hospital of Nanjing University Medical School approved this retrospective study and waived the requirement for written informed consent. All included patients\u2019 personal information is strictly confidential. This study followed the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}